Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Clinical trial NCT05978284 · RECRUITING
Trial details
- NCT number
- NCT05978284
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-27
- Primary completion
- 2026-09-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.